NASDAQ: NAGE
Niagen Bioscience Inc Stock Ownership - Who owns Niagen Bioscience?

Insider buying vs selling

Have Niagen Bioscience Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Robert N. FriedChief Executive Officer2025-04-0966,667$3.30
$220.00kBuy
Carlos Luis LopezSVP General Counsel2025-03-07273$7.86
$2.15kBuy
Frank L. Jaksch Jr.Director2024-12-1350,001$3.66
$183.00kBuy
Frank L. Jaksch Jr.Director2024-12-1337,161$6.19
$229.95kSell
Ozan PamirChief Financial Officer2024-11-222,907$7.36
$21.40kBuy
Kristin PatrickDirector2024-08-2323,000$3.57
$82.11kSell
Kristin PatrickDirector2024-08-2320,000$1.67
$33.40kBuy
Kristin PatrickDirector2024-08-233,000$1.64
$4.92kBuy

1 of 1

NAGE insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NAGE insiders and whales buy or sell their stock.

NAGE Shareholders

What type of owners hold Niagen Bioscience Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Hoi Shuen Solina Holly Chau32.59%25,672,139$265.83MInsider
Barry C. Honig26.84%21,143,044$218.94MInsider
Champion River Ventures Ltd24.56%19,349,652$200.37MInsider
Michael Brauser19.32%15,219,914$157.60MInsider
Frank L. Jaksch Jr.18.10%14,260,386$147.67MInsider
Phillip Md Et Al Frost16.00%12,602,939$130.50MInsider
Sheep Flp Black7.90%6,225,155$64.46MInsider
Tricia A. Jaksch7.90%6,225,155$64.46MInsider
Margie Chassman5.60%4,408,640$45.65MInsider
Pioneer Step Holdings Ltd4.88%3,846,155$39.83MInsider

1 of 3

NAGE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NAGE15.04%84.96%Net Buying
GERN80.03%1.09%Net BuyingNet Buying
SNDX91.93%8.07%Net BuyingNet Buying
ORIC78.64%21.36%Net SellingNet Selling
NUVB56.52%43.48%Net BuyingNet Buying

Niagen Bioscience Stock Ownership FAQ

Who owns Niagen Bioscience?

Niagen Bioscience (NASDAQ: NAGE) is owned by 31.61% institutional shareholders, 178.53% Niagen Bioscience insiders, and 0.00% retail investors. Hoi Shuen Solina Holly Chau is the largest individual Niagen Bioscience shareholder, owning 25.67M shares representing 32.59% of the company. Hoi Shuen Solina Holly Chau's Niagen Bioscience shares are currently valued at $260.83M.

If you're new to stock investing, here's how to buy Niagen Bioscience stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.